SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-024053
Filing Date
2020-02-24
Accepted
2020-02-24 06:06:42
Documents
14
Period of Report
2020-02-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2010751-1_8k.htm   iXBRL 8-K 26334
2 EXHIBIT 99-1 tm2010751d1_ex99-1.htm EX-99.1 25599
3 EXHIBIT 99-2 tm2010751d1_ex99-2.htm EX-99.2 29991
  Complete submission text file 0001104659-20-024053.txt   270727

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA uthr-20200224.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20200224_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20200224_pre.xml EX-101.PRE 22708
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2010751-1_8k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 20641953
SIC: 2834 Pharmaceutical Preparations